To our knowledge, only 5 cases have been reported until now.[9] Herein, for the first time, we report a patient diagnosed with PBC and SS who developed AIHA after 32 months of UDCA therapy with decreased AMA titers and increased anti-nuclear rim antibody titers, specifically anti-gp210. The gene discussed is NUP210; the disease is primary biliary cholangitis.